Importance of the profile of inflammatory and anti-inflammatory cytokines in patients with Hepatitis C according to degrees of fibrosis.

IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Abigail Hernandez-Barragan , Moisés Martínez-Castillo , Adrián Flores-Sánchez , Jesús Dorantes-Alvarez , Isabel Villagómez-López , Marisela Hernandez-Santillan , Andrea Garcia-Avalos , José Luis Pérez-Hernández , Fátima Higuera-De la Tijera , Paula Cordero-Pérez , Linda Muñoz-Espinosa , Gabriela Gutierrez-Reyes
{"title":"Importance of the profile of inflammatory and anti-inflammatory cytokines in patients with Hepatitis C according to degrees of fibrosis.","authors":"Abigail Hernandez-Barragan ,&nbsp;Moisés Martínez-Castillo ,&nbsp;Adrián Flores-Sánchez ,&nbsp;Jesús Dorantes-Alvarez ,&nbsp;Isabel Villagómez-López ,&nbsp;Marisela Hernandez-Santillan ,&nbsp;Andrea Garcia-Avalos ,&nbsp;José Luis Pérez-Hernández ,&nbsp;Fátima Higuera-De la Tijera ,&nbsp;Paula Cordero-Pérez ,&nbsp;Linda Muñoz-Espinosa ,&nbsp;Gabriela Gutierrez-Reyes","doi":"10.1016/j.aohep.2025.101858","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>The cure for chronic Hepatitis C (HCV) is a milestone for humanity, however, patients could still progress toward hepatocellular carcinoma even after receiving direct-acting antiviral treatment [1]. Therefore, determining the inflammatory (IFN-γ, TNF-α), and anti-inflammatory (IL-10- IL-1RA) profiles in patients with different degree of liver fibrosis are the important aim in researching of new biomarkers.</div></div><div><h3>Materials and Methods</h3><div>Prospective, cross-sectional and multicenter study; approved through the ethics committee of the UNAM, and the Hospital General de Mexico, patients with chronic Hepatitis C (CHC), and healthy subjects (control group) were included. A personalized survey of chronic and recent pathologies, as well as alcohol consumption, was performed in all the subjects. Biochemical and hematological laboratory test were performed, including Fibroscan and/or Fibrotest to determinate the degree of fibrosis. In addition, the cytokine profile (IFN-γ, TNF-α, IL-10 and IL-1RA) was quantified in the serum by multiple suspension array. The data was analyzed by Kruskal-Wallis, Mann-Whitney U and ANOVA statistical tests by SPSS v.22 software, considering p &gt; 0.05</div></div><div><h3>Results</h3><div>A total of 180 CT subjects were included; whereas 90 patients with CHC with different grades of fibrosis: F0=20, F1=15, F2=15, F3=16 and F4=24, were enrolled. As has been studied, Hepatitis C Virus inhibits the activity of IFN-γ, despite of this, its concentration has been controversial in different populations. In our population, the levels were low with the exception for F2 (p&lt;0.01). Another important factor of inflammation is TNF-α, which was found increased in all stages: F0-F4 and in F2 up to 6 times more than the CT and F4 groups (p&lt;0.001). When analyzing the results of anti-inflammatory cytokines; the highest concentration of IL-10 was observed in F2 (increased up to 7 times) (p&lt;0.001), while for IL-1RA in F2 it was found to be increased up to 10 times more than in F1 and F3 (p&lt;0.05); what it shows that in F2 the inflammatory/anti-inflammatory microenvironment at the peripheral level has more activity. On the other hand, the highest concentration of IL-1RA was observed in F4, which may be actively participating in the repair due to decreased mediators of inflammation.</div></div><div><h3>Conclusions</h3><div>The F2 stage is an important turning point, indicating a shift in the microenvironment due to the accumulation of the extracellular matrix, making it clear the importance of measuring inflammation at intermediate stages of fibrosis, which would allow for impacting the limitation of the hepatic fibrogenic process.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101858"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125000821","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and Objectives

The cure for chronic Hepatitis C (HCV) is a milestone for humanity, however, patients could still progress toward hepatocellular carcinoma even after receiving direct-acting antiviral treatment [1]. Therefore, determining the inflammatory (IFN-γ, TNF-α), and anti-inflammatory (IL-10- IL-1RA) profiles in patients with different degree of liver fibrosis are the important aim in researching of new biomarkers.

Materials and Methods

Prospective, cross-sectional and multicenter study; approved through the ethics committee of the UNAM, and the Hospital General de Mexico, patients with chronic Hepatitis C (CHC), and healthy subjects (control group) were included. A personalized survey of chronic and recent pathologies, as well as alcohol consumption, was performed in all the subjects. Biochemical and hematological laboratory test were performed, including Fibroscan and/or Fibrotest to determinate the degree of fibrosis. In addition, the cytokine profile (IFN-γ, TNF-α, IL-10 and IL-1RA) was quantified in the serum by multiple suspension array. The data was analyzed by Kruskal-Wallis, Mann-Whitney U and ANOVA statistical tests by SPSS v.22 software, considering p > 0.05

Results

A total of 180 CT subjects were included; whereas 90 patients with CHC with different grades of fibrosis: F0=20, F1=15, F2=15, F3=16 and F4=24, were enrolled. As has been studied, Hepatitis C Virus inhibits the activity of IFN-γ, despite of this, its concentration has been controversial in different populations. In our population, the levels were low with the exception for F2 (p<0.01). Another important factor of inflammation is TNF-α, which was found increased in all stages: F0-F4 and in F2 up to 6 times more than the CT and F4 groups (p<0.001). When analyzing the results of anti-inflammatory cytokines; the highest concentration of IL-10 was observed in F2 (increased up to 7 times) (p<0.001), while for IL-1RA in F2 it was found to be increased up to 10 times more than in F1 and F3 (p<0.05); what it shows that in F2 the inflammatory/anti-inflammatory microenvironment at the peripheral level has more activity. On the other hand, the highest concentration of IL-1RA was observed in F4, which may be actively participating in the repair due to decreased mediators of inflammation.

Conclusions

The F2 stage is an important turning point, indicating a shift in the microenvironment due to the accumulation of the extracellular matrix, making it clear the importance of measuring inflammation at intermediate stages of fibrosis, which would allow for impacting the limitation of the hepatic fibrogenic process.
根据纤维化程度,丙型肝炎患者炎症和抗炎细胞因子的重要性。
慢性丙型肝炎(HCV)的治愈是人类的一个里程碑,然而,即使在接受直接抗病毒治疗后,患者仍可能进展为肝细胞癌。因此,确定不同程度肝纤维化患者的炎症(IFN-γ、TNF-α)和抗炎(IL-10- IL-1RA)谱是研究新的生物标志物的重要目的。材料与方法前瞻性、横断面、多中心研究;经墨西哥国立自治大学伦理委员会和墨西哥总医院批准,纳入慢性丙型肝炎(CHC)患者和健康受试者(对照组)。对所有受试者进行了慢性和近期病理以及酒精消费的个性化调查。进行生化和血液学实验室检查,包括Fibroscan和/或Fibrotest以确定纤维化程度。此外,采用多重悬液阵列法测定血清中细胞因子(IFN-γ、TNF-α、IL-10和IL-1RA)的含量。数据采用Kruskal-Wallis、Mann-Whitney U统计检验,采用SPSS v.22软件进行ANOVA统计检验,考虑p >;0.05结果共纳入180例CT受试者;90例不同纤维化程度的CHC患者,F0=20, F1=15, F2=15, F3=16, F4=24。据研究,丙型肝炎病毒抑制IFN-γ的活性,尽管如此,其浓度在不同人群中一直存在争议。在我们的人群中,除F2外,水平较低(p<0.01)。炎症的另一个重要因素是TNF-α,在所有阶段均升高:F0-F4和F2组比CT组和F4组高6倍(p<0.001)。在分析抗炎细胞因子结果时;F2组IL-10浓度最高(增加了7倍)(p<0.001), F2组IL-1RA浓度增加了10倍(p<0.05);这表明在F2中外周水平的炎症/抗炎微环境更活跃。另一方面,F4中IL-1RA浓度最高,可能是由于炎症介质减少而积极参与修复。结论F2期是一个重要的转折点,表明微环境由于细胞外基质的积累而发生了变化,这表明在纤维化中期测量炎症的重要性,这可能会影响肝纤维化过程的局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of hepatology
Annals of hepatology 医学-胃肠肝病学
CiteScore
7.90
自引率
2.60%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信